首页|期刊导航|北京中医药|基于VEGF/ANG通路探究固本抑瘤Ⅱ号对三阴性乳腺癌术后自发肺转移的作用机制

基于VEGF/ANG通路探究固本抑瘤Ⅱ号对三阴性乳腺癌术后自发肺转移的作用机制OA

Mechanisms of Guben Yiliu No.2 in inhibiting postoperative lung metastasis of triple-negative breast cancer mice via the VEGF/ANG pathway

中文摘要英文摘要

目的 探究固本抑瘤Ⅱ号通过血管内皮生长因子/血管生成素(VEGF/ANG)通路减少肿瘤血管生成,进而抑制三阴性乳腺癌(TNBC)小鼠术后肺转移的作用和机制.方法 将25只雌性Balb/c小鼠,随机分为空白组、模型组、术后中药组、全程中药组、表柔比星组,每组5只.采用4T1-luciferase细胞第4乳垫原位接种+术后切除原位瘤法构建TNBC术后自发肺转移模型,术后中药组于术后第3天,全程中药组于接种后第3天开始用固本抑瘤Ⅱ号[60 mL/(kg·d)]灌胃,表柔比星组腹腔注射表柔比星(0.003 g/kg,1周2次),空白组与模型组给予等体积生理盐水.通过小动物活体可见光成像、micro-CT评估肺转移情况.免疫组织化学血小板内皮细胞黏附分子-1/过碘酸-雪夫染色(CD31/PAS)检测血管生成拟态;蛋白免疫印迹检测肺组织血管内皮生长因子A(VEGFA)、血管生成素-1(ANG1)、血管生成素-2(ANG2)、酪氨酸激酶受体2(Tie2)等蛋白表达;酶联免疫吸附试验(ELISA)检测血清VEGF水平;免疫荧光检测肺组织紧密连接蛋白-1(claudin-1)表达.通过体外肺微血管内皮细胞(PMVEC)与4T1细胞共培养,检测细胞成管能力及血管通透性.结果 与模型组比较,全程中药组肺转移灶荧光强度、肺质量及肺指数均显著降低(P<0.05),肺组织MVD、VM密度显著下降(P<0.05),claudin-1荧光强度显著增强(P<0.05);血清VEGF及肺组织VEGFA、ANG2蛋白表达显著下调(P<0.05),ANG1及Tie2表达呈上升趋势.体外实验中,固本抑瘤Ⅱ号显著抑制PMVEC成管结构数、成管长度及节点数(P<0.05),降低FITC-葡聚糖渗漏量(P<0.05),而表柔比星反而增加其渗透量.结论 固本抑瘤Ⅱ号可有效抑制TNBC小鼠术后肺转移,其机制可能是通过调控VEGF/ANG通路,抑制肿瘤血管生成、降低肺微血管通透性,从而阻止转移前生态位形成.

Objective To investigate the effects and mechanisms of Guben Yiliu No.2 in inhibiting postoperative lung metastasis of triple-negative breast cancer(TNBC)in mice by reducing tumor angiogenesis through the vascular endothelial growth factor/angiopoietin(VEGF/ANG)pathway.Methods Twenty-five female BALB/c mice were randomly divided into a blank group,model group,postoperative traditional Chinese medicine(TCM)group,whole-course TCM group,and epirubicin group,with 5 mice in each group.A spontaneous postoperative lung metastasis model of TNBC was established by orthotopic inoculation of 4T1-luciferase cells into the fourth mammary fat pad followed by surgical resection of the primary tumor.The postoperative TCM group received Guben Yiliu No.2(60 mL/kg·d)by gavage starting on postoperative day 3,while the whole-course TCM group received the same treatment beginning on day 3 after tumor inoculation.The epirubicin group received intraperitoneal injections of epirubicin(0.003 g/kg,twice weekly).The blank and model groups received equal volumes of normal saline.Lung metastasis was evaluated by small-animal in vivo bioluminescence imaging and micro-CT.Vasculogenic mimicry(VM)was detected by immunohistochemical staining for platelet endothelial cell adhesion molecule-1/periodic acid-Schiff(CD31/PAS).Protein expression levels of vascular endothelial growth factor A(VEGFA),angiopoietin-1(ANG1),angiopoietin-2(ANG2),and tyrosine kinase receptor 2(Tie2)in lung tissue were detected by Western blot.Serum VEGF levels were measured by enzyme-linked immunosorbent assay(ELISA).Expression of the tight junction protein-1(claudin-1)in lung tissue was detected by immunofluorescence.In vitro,pulmonary microvascular endothelial cells(PMVECs)were co-cultured with 4T1 cells to evaluate tube formation ability and vascular permeability.Results Compared with the model group,the whole-course TCM group showed significantly reduced fluorescence intensity of lung metastatic lesions,lung weight,and lung index(P<0.05),significantly decreased microvessel density(MVD)and VM density in lung tissue(P<0.05),and significantly enhanced claudin-1 fluorescence intensity(P<0.05).Serum VEGF levels and protein expression levels of VEGFA and ANG2 in lung tissue were significantly downregulated(P<0.05),whereas ANG1 and Tie2 expression levels showed an upward trend.In vitro experiments demonstrated that Guben Yiliu No.2 significantly inhibited the number of PMVEC tube structures,tube length,and node number(P<0.05),and reduced FITC-dextran leakage(P<0.05),whereas epirubicin increased vascular permeability.Conclusion Guben Yiliu No.2 effectively inhibits postoperative lung metastasis in TNBC mice.The underlying mechanism may involve regulation of the VEGF/ANG pathway,inhibition of tumor angiogenesis,and reduction of pulmonary microvascular permeability,thereby preventing the formation of the premetastatic niche.

左曦;王笑民;南凌杉;殷晓辉;陈栋;张甘霖

北京中医药大学,北京 100029首都医科大学附属北京中医医院肿瘤科,北京 100010北京中医药大学,北京 100029北京中医药大学,北京 100029首都医科大学附属北京中医医院肿瘤科,北京 100010首都医科大学附属北京中医医院肿瘤科,北京 100010

三阴性乳腺癌术后自发肺转移固本抑瘤Ⅱ号中医药血管生成血管通透性小鼠

triple-negative breast cancer(TNBC)postoperative spontaneous lung metastasisGuben Yiliu No.2traditional Chinese medicineangiogenesisvascular permeabilitymice

《北京中医药》 2026 (4)

452-460,9

国家自然科学基金项目(82274599)

10.16025/j.1674-1307.2026.04.005

评论